{
  "$schema": "folio-library-document/v1",
  "id": "10665-67839",
  "title": "Second meeting of the Global Working Group on TB/HIV : 14-16 June 2002, Durban, South Africa",
  "variant": "pdf",
  "pages": 66,
  "tocSource": "inferred",
  "tocMethod": "contents",
  "toc": [
    {
      "level": 1,
      "title": "Glossary of abbreviations",
      "number": null,
      "page": 6,
      "pageLabel": "5",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-000-glossary-of-abbreviations"
    },
    {
      "level": 1,
      "title": "Executive summary",
      "number": null,
      "page": 8,
      "pageLabel": "7",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-001-executive-summary"
    },
    {
      "level": 1,
      "title": "Report",
      "number": null,
      "page": 12,
      "pageLabel": "11",
      "confidence": 0.65,
      "evidence": [
        "contents",
        "style"
      ],
      "source": "inferred",
      "section": "sec-002-report"
    },
    {
      "level": 1,
      "title": "Background and objectives",
      "number": "1",
      "page": 12,
      "pageLabel": "11",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-004-1-background-and-objectives"
    },
    {
      "level": 2,
      "title": "New developments",
      "number": "1.2",
      "page": 12,
      "pageLabel": "11",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-003-12-new-developments"
    },
    {
      "level": 2,
      "title": "Objectives",
      "number": "1.3",
      "page": 13,
      "pageLabel": "12",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-005-13-objectives"
    },
    {
      "level": 2,
      "title": "Country presentations",
      "number": "2.1",
      "page": 14,
      "pageLabel": "13",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-006-21-country-presentations"
    },
    {
      "level": 2,
      "title": "Presentations from international organizations",
      "number": "2.2",
      "page": 16,
      "pageLabel": "15",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-007-22-presentations-from-international-organization"
    },
    {
      "level": 1,
      "title": "Progress with joint TB/HIV interventions",
      "number": "3",
      "page": 22,
      "pageLabel": "21",
      "confidence": 0.8,
      "evidence": [
        "contents",
        "body",
        "number"
      ],
      "source": "inferred",
      "section": "sec-009-3-progress-with-joint-tbhiv-interventions"
    },
    {
      "level": 2,
      "title": "ProTEST",
      "number": "3.1",
      "page": 22,
      "pageLabel": "21",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-008-31-protest"
    },
    {
      "level": 2,
      "title": "Country experiences",
      "number": "3.2",
      "page": 23,
      "pageLabel": "22",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-010-32-country-experiences"
    },
    {
      "level": 1,
      "title": "activities",
      "number": null,
      "page": 32,
      "pageLabel": "31",
      "confidence": 0.5,
      "evidence": [
        "contents"
      ],
      "source": "inferred",
      "section": "sec-012-activities"
    },
    {
      "level": 2,
      "title": "Presentation of the guidelines",
      "number": "4.1",
      "page": 32,
      "pageLabel": "31",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-011-41-presentation-of-the-guidelines"
    },
    {
      "level": 2,
      "title": "Discussion",
      "number": "4.2",
      "page": 33,
      "pageLabel": "32",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-013-42-discussion"
    },
    {
      "level": 1,
      "title": "Anti-retroviral treatment (ART)",
      "number": "5",
      "page": 34,
      "pageLabel": "33",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-015-5-anti-retroviral-treatment-art"
    },
    {
      "level": 2,
      "title": "Experience in Brazil",
      "number": "5.1",
      "page": 34,
      "pageLabel": "33",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-014-51-experience-in-brazil"
    },
    {
      "level": 2,
      "title": "Experience in Malawi",
      "number": "5.2",
      "page": 35,
      "pageLabel": "34",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-016-52-experience-in-malawi"
    },
    {
      "level": 2,
      "title": "WHO guidelines",
      "number": "5.3",
      "page": 35,
      "pageLabel": "34",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-017-53-who-guidelines"
    },
    {
      "level": 2,
      "title": "Discussion",
      "number": "5.4",
      "page": 36,
      "pageLabel": "35",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-018-54-discussion"
    },
    {
      "level": 1,
      "title": "Directions suggested by epidemiological modelling",
      "number": "6",
      "page": 38,
      "pageLabel": "37",
      "confidence": 0.8,
      "evidence": [
        "contents",
        "body",
        "number"
      ],
      "source": "inferred",
      "section": "sec-020-6-directions-suggested-by-epidemiological-modell"
    },
    {
      "level": 2,
      "title": "The impact of available interventions",
      "number": "6.1",
      "page": 38,
      "pageLabel": "37",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-019-61-the-impact-of-available-interventions"
    },
    {
      "level": 2,
      "title": "Implications of an analysis of the TB and HIV epidemics",
      "number": "6.2",
      "page": 39,
      "pageLabel": "38",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-021-62-implications-of-an-analysis-of-the-tb-and-hiv"
    },
    {
      "level": 2,
      "title": "Discussion",
      "number": "6.3",
      "page": 41,
      "pageLabel": "40",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-022-63-discussion"
    },
    {
      "level": 1,
      "title": "Constraints and recommendations to overcome them",
      "number": "7",
      "page": 42,
      "pageLabel": "41",
      "confidence": 0.8,
      "evidence": [
        "contents",
        "body",
        "number"
      ],
      "source": "inferred",
      "section": "sec-023-7-constraints-and-recommendations-to-overcome-th"
    },
    {
      "level": 2,
      "title": "Advocacy and Information, Education & Communication",
      "number": "7.2",
      "page": 43,
      "pageLabel": "42",
      "confidence": 0.8,
      "evidence": [
        "contents",
        "body",
        "number"
      ],
      "source": "inferred",
      "section": "sec-024-72-advocacy-and-information-education-communicat"
    },
    {
      "level": 2,
      "title": "Surveillance, monitoring and evaluation",
      "number": "7.3",
      "page": 43,
      "pageLabel": "42",
      "confidence": 0.8,
      "evidence": [
        "contents",
        "body",
        "number"
      ],
      "source": "inferred",
      "section": "sec-025-73-surveillance-monitoring-and-evaluation"
    },
    {
      "level": 2,
      "title": "Provision and improvement of clinical care",
      "number": "7.4",
      "page": 44,
      "pageLabel": "43",
      "confidence": 0.8,
      "evidence": [
        "contents",
        "body",
        "number"
      ],
      "source": "inferred",
      "section": "sec-026-74-provision-and-improvement-of-clinical-care"
    },
    {
      "level": 2,
      "title": "Scaling up joint activities",
      "number": "7.5",
      "page": 45,
      "pageLabel": "44",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-027-75-scaling-up-joint-activities"
    },
    {
      "level": 2,
      "title": "Summary of key recommendations",
      "number": "7.6",
      "page": 46,
      "pageLabel": "45",
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-028-76-summary-of-key-recommendations"
    },
    {
      "level": 1,
      "title": "Meeting agenda",
      "number": "Annex 1",
      "page": 48,
      "pageLabel": null,
      "confidence": 0.55,
      "evidence": [
        "contents",
        "number"
      ],
      "source": "inferred",
      "section": null
    },
    {
      "level": 1,
      "title": "List of participants",
      "number": "Annex 2",
      "page": 54,
      "pageLabel": null,
      "confidence": 0.95,
      "evidence": [
        "contents",
        "body",
        "style",
        "number"
      ],
      "source": "inferred",
      "section": "sec-029-annex-2-list-of-participants"
    }
  ],
  "sections": [
    {
      "id": "sec-front-matter",
      "number": null,
      "title": "Front matter",
      "level": 1,
      "pageStart": 1,
      "pageEnd": 6,
      "labelStart": null,
      "labelEnd": "5",
      "words": 1682,
      "summary": {
        "text": "Front matter of the report of the second meeting of the Global Working Group on TB/HIV, held in Durban, South Africa, on 14–16 June 2002, giving the document number, funders and the rapporteur and contributors. It notes that the working group is one of six under the Global Stop TB Partnership. The rest is the table of contents, listing the report's chapters and annexes on the agenda and participants.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "global working",
          "heading": false
        },
        {
          "term": "working group",
          "heading": false
        },
        {
          "term": "hiv june",
          "heading": false
        },
        {
          "term": "presentations",
          "heading": false
        },
        {
          "term": "south africa",
          "heading": false
        },
        {
          "term": "durban",
          "heading": false
        },
        {
          "term": "health organization",
          "heading": false
        },
        {
          "term": "meeting",
          "heading": false
        }
      ],
      "extract": "SECOND MEETING OF THE GLOBAL WORKING GROUP ON TB/HIV 14-16 June 2002 Durban, South Africa WORLD HEALTH ORGANIZATION WHO/CDS/TB/2002.311 SECOND MEETING OF THE GLOBAL WORKING GROUP ON TB/HIV 14-16 June 2002 Durban, South Africa Stop TB Department, World Health Organization (on behalf of the Global Working Group on TB/HIV) WHO/CDS/TB/2002.311 This meeting was supported by the Global AIDS Program, Centers for Disease",
      "extractCut": true,
      "blocks": [
        "library/10665-67839/blocks/prose-sec-front-matter"
      ]
    },
    {
      "id": "sec-000-glossary-of-abbreviations",
      "number": null,
      "title": "Glossary of abbreviations",
      "level": 1,
      "pageStart": 6,
      "pageEnd": 8,
      "labelStart": "5",
      "labelEnd": "7",
      "words": 704,
      "summary": {
        "text": "A glossary of abbreviations used in the report, followed by the start of the executive summary. The summary notes that the working group first met in 2001 and that the Durban meeting drew 130 participants from 35 countries. It sets out the meeting's objectives and mentions the country presentations, including Brazil's progress with antiretroviral therapy.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "anti-retroviral treatment",
          "heading": false
        },
        {
          "term": "hiv aids",
          "heading": false
        },
        {
          "term": "meeting heard",
          "heading": false
        },
        {
          "term": "protest approach",
          "heading": false
        },
        {
          "term": "aids programme",
          "heading": false
        },
        {
          "term": "transcriptase inhibitor",
          "heading": false
        },
        {
          "term": "reverse transcriptase",
          "heading": false
        },
        {
          "term": "national aids",
          "heading": false
        }
      ],
      "extract": "GLOSSARY OF ABBREVIATIONS 3TC LAMIVUDINE ABC ABACAVIR ACF ACTIVE CASE FINDING AFRO WHO REGIONAL OFFICE FOR AFRICA AIDS ACQUIRED IMMUNODEFICIENCY SYNDROME ART ANTI-RETROVIRAL TREATMENT ARV ANTI-RETROVIRAL CBO COMMUNITY-BASED ORGANIZATION CD4 ANTIGEN IDENTIFYING T HELPER LYMPHOCYTES CDC-GAP GLOBAL AIDS PROGRAM, CENTERS OF DISEASE CONTROL AND PREVENTION CPT CO-TRIMOXAZOLE PREVENTIVE TREATMENT DOTS DIRECTLY-OBSERVED",
      "extractCut": true
    },
    {
      "id": "sec-001-executive-summary",
      "number": null,
      "title": "Executive summary",
      "level": 1,
      "pageStart": 8,
      "pageEnd": 12,
      "labelStart": "7",
      "labelEnd": "11",
      "words": 1022,
      "summary": {
        "text": "Continues the executive summary with the perspectives of international agencies and WHO offices, the progress of the ProTEST initiative, and key issues raised, such as data collection, patients falling between TB and HIV programmes and adherence to preventive treatment. It reports that the draft guidelines on collaborative TB/HIV activities were endorsed subject to shortening, and introduces the main recommendations and the working group's background.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "executive summary",
          "heading": true
        },
        {
          "term": "hiv activities",
          "heading": false
        },
        {
          "term": "hiv aids",
          "heading": false
        },
        {
          "term": "urges",
          "heading": false
        },
        {
          "term": "aids department",
          "heading": false
        },
        {
          "term": "hiv strategic",
          "heading": false
        },
        {
          "term": "hiv prevalence",
          "heading": false
        },
        {
          "term": "global working",
          "heading": false
        }
      ],
      "extract": "EXECUTIVE SUMMARY xecutive Summary E Several international agencies provided their perspectives: the World Bank, UNAIDS and USAID. Contributions were made by WHO regional offices (Africa, Southeast Asia and Western Pacific) and by WHO’s Department of HIV/AIDS/STIs. There was a summary of international progress with the ProTEST initiative, the formal evaluation of which is still under way. Issues arising which were",
      "extractCut": true
    },
    {
      "id": "sec-002-report",
      "number": null,
      "title": "Report",
      "level": 1,
      "pageStart": 12,
      "pageEnd": 12,
      "labelStart": "11",
      "labelEnd": "11",
      "words": 43,
      "summary": {
        "text": "Recalls that the first meeting discussed the ProTEST approach and gave its endorsement to WHO's Strategic Framework for reducing the TB/HIV burden.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "protest",
          "heading": false
        },
        {
          "term": "pilot",
          "heading": false
        },
        {
          "term": "decrease",
          "heading": false
        }
      ],
      "extract": "epidemic and the need to step up action against it. The ProTEST approach to addressing TB/HIV was also discussed, and initial experiences with pilot ProTEST projects were shared. The meeting reviewed and endorsed the WHO Strategic Framework to Decrease the Burden of TB/HIV.",
      "extractCut": false
    },
    {
      "id": "sec-003-12-new-developments",
      "number": "1.2",
      "title": "New developments",
      "level": 2,
      "pageStart": 12,
      "pageEnd": 12,
      "labelStart": "11",
      "labelEnd": "11",
      "words": 214,
      "summary": {
        "text": "Lists developments since the first meeting, such as publication of the Strategic Framework, draft guidelines on collaborative activities, a protocol workshop in Nairobi, TB modelling work, a new core group and updated estimates of HIV-associated TB.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "developments",
          "heading": true
        },
        {
          "term": "hiv programme",
          "heading": false
        },
        {
          "term": "programme activities",
          "heading": false
        },
        {
          "term": "secretariat",
          "heading": false
        },
        {
          "term": "meeting",
          "heading": false
        },
        {
          "term": "presented",
          "heading": false
        }
      ],
      "extract": "The secretariat managed the following developments between the first and the second WG meetings. • The Strategic Framework to Decrease the Burden of TB/HIV was published and disseminated. Two WHO regional offices (EURO and WPRO) have made progress in adapting the framework for their regions. • The Scientific Panel of the WG prepared guidelines for implementing collaborative TB and HIV programme activities. These",
      "extractCut": true
    },
    {
      "id": "sec-004-1-background-and-objectives",
      "number": "1",
      "title": "Background and objectives",
      "level": 1,
      "pageStart": 12,
      "pageEnd": 13,
      "labelStart": "11",
      "labelEnd": "12",
      "words": 166,
      "summary": {
        "text": "Notes policy changes between the two meetings, including the creation of the Global Fund to Fight AIDS, Tuberculosis and Malaria, to which several countries had applied, and grants of TB drugs to 23 countries by the Global TB Drug Facility.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "background",
          "heading": true
        },
        {
          "term": "objectives",
          "heading": true
        },
        {
          "term": "pledges",
          "heading": false
        },
        {
          "term": "april",
          "heading": false
        },
        {
          "term": "gfatm",
          "heading": false
        }
      ],
      "extract": "BACKGROUND AND OBJECTIVES Background and objectives 1 eport R 1.1 1.2 1 First Meeting of the Global Working Group on TB/HIV, 9-11 April 2001, Geneva, Switzerland. WHO/CDS/TB/2001.293 Significant changes in the policy environment that took place between the meetings included: • In April 2001, the UN Secretary General issued a call to action for the creation of a Global Fund to fight HIV/AIDS, TB and Malaria (GFATM).",
      "extractCut": true
    },
    {
      "id": "sec-005-13-objectives",
      "number": "1.3",
      "title": "Objectives",
      "level": 2,
      "pageStart": 13,
      "pageEnd": 14,
      "labelStart": "12",
      "labelEnd": "13",
      "words": 132,
      "summary": {
        "text": "Lists the meeting's objectives: reviewing progress with joint TB and HIV activities, making practical recommendations, sharing country experience, shifting the group's focus to country implementation, and finalising the collaborative activity guidelines.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "hiv activities",
          "heading": false
        },
        {
          "term": "working group",
          "heading": false
        },
        {
          "term": "finalise",
          "heading": false
        },
        {
          "term": "joint",
          "heading": false
        }
      ],
      "extract": "The objectives of the second meeting were as follows. • To determine progress with joint TB and HIV activities and identify opportunities and constraints at international and national levels. • To produce practical recommendations for the expansion of joint actions against TB/HIV by TB and HIV/AIDS programmes. • To share experiences (at country and regional level) regarding both the prevalence of TB/HIV coinfection",
      "extractCut": true
    },
    {
      "id": "sec-006-21-country-presentations",
      "number": "2.1",
      "title": "Country presentations",
      "level": 2,
      "pageStart": 14,
      "pageEnd": 16,
      "labelStart": "13",
      "labelEnd": "15",
      "words": 948,
      "summary": {
        "text": "Summarises country presentations on TB/HIV from Senegal, Nigeria, Malawi and Cambodia, covering HIV prevalence, TB burden and treatment outcomes, programme structures and plans for collaboration. Plans mentioned include expanding counselling and testing, home-based care and preventive therapy.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "hiv aids",
          "heading": false
        },
        {
          "term": "national aids",
          "heading": false
        },
        {
          "term": "aids council",
          "heading": false
        },
        {
          "term": "aids control",
          "heading": false
        },
        {
          "term": "presentations",
          "heading": true
        },
        {
          "term": "hiv activities",
          "heading": false
        },
        {
          "term": "hiv prevalence",
          "heading": false
        },
        {
          "term": "joint activities",
          "heading": false
        }
      ],
      "extract": "Senegal Dr Mandiaye Loume (Director of Health, Ministry of Health and Prevention Senegal) described efforts to integrate TB and AIDS control efforts. There have been an estimated 30,000 AIDS deaths in Senegal. HIV prevalence is estimated at 1.4%. Two governing bodies were established to deal with HIV/AIDS: the National AIDS Control Committee (NACC) and the National AIDS Control Programme (NACP). The NACC has now",
      "extractCut": true
    },
    {
      "id": "sec-007-22-presentations-from-international-organization",
      "number": "2.2",
      "title": "Presentations from international organizations",
      "level": 2,
      "pageStart": 16,
      "pageEnd": 22,
      "labelStart": "15",
      "labelEnd": "21",
      "words": 2275,
      "summary": {
        "text": "Summarises presentations from international organisations, including the World Bank's Multi-country AIDS Programme for Africa, UNAIDS advocacy and regional support, and USAID funding for TB/HIV. It also covers WHO regional offices, the WHO HIV/AIDS department and research on causes of death among people with HIV. A study is cited showing that cryptococcosis was the most common cause of death while TB caused few, and the section concludes that effective TB control offers the best immediate chance to improve survival.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "hiv aids",
          "heading": false
        },
        {
          "term": "aids care",
          "heading": false
        },
        {
          "term": "aids control",
          "heading": false
        },
        {
          "term": "hiv activities",
          "heading": false
        },
        {
          "term": "aids prevention",
          "heading": false
        },
        {
          "term": "aids policy",
          "heading": false
        },
        {
          "term": "aids programmes",
          "heading": false
        },
        {
          "term": "hiv prevalence",
          "heading": false
        }
      ],
      "extract": "The World Bank Dr K Hansen, Manager of the World Bank AIDS Campaign Team for Africa, outlined the position of TB/HIV in the Bank’s Multi-country AIDS Programme for Africa (MAP). US$1bn is available to scale up and intensify existing activities; 15 countries will be receiving $517m and programmes for a further 12 countries are already in preparation. The Bank is thinking in terms of multi-sectoral, multi-",
      "extractCut": true
    },
    {
      "id": "sec-008-31-protest",
      "number": "3.1",
      "title": "ProTEST",
      "level": 2,
      "pageStart": 22,
      "pageEnd": 22,
      "labelStart": "21",
      "labelEnd": "21",
      "words": 374,
      "summary": {
        "text": "Summarises achievements of the ProTEST projects in South Africa, Malawi and Zambia, which increased uptake of HIV counselling and testing and isoniazid preventive therapy but had poor adherence. It lists next steps, including phased implementation proposals from eight countries.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "protest",
          "heading": true
        },
        {
          "term": "protest projects",
          "heading": false
        },
        {
          "term": "vct",
          "heading": false
        },
        {
          "term": "preventive therapy",
          "heading": false
        },
        {
          "term": "case finding",
          "heading": false
        },
        {
          "term": "ipt",
          "heading": false
        },
        {
          "term": "utilising",
          "heading": false
        },
        {
          "term": "cpt",
          "heading": false
        }
      ],
      "extract": "A summary Dr Philip Onyebujoh, from Stop TB, WHO, looked at achievements made so far in the ProTEST projects, supported by WHO, USAID and CDC-GAP. The strategies of ProTEST are: to reduce HIV transmission through quality VCT services, promotion of condoms, and, where possible, to treatment of STIs; to reduce TB transmission through active case finding (ACF) and enhanced case-holding; to reduce TB reactivation",
      "extractCut": true
    },
    {
      "id": "sec-009-3-progress-with-joint-tbhiv-interventions",
      "number": "3",
      "title": "Progress with joint TB/HIV interventions",
      "level": 1,
      "pageStart": 22,
      "pageEnd": 23,
      "labelStart": "21",
      "labelEnd": "22",
      "words": 349,
      "summary": {
        "text": "Outlines further next steps for phased implementation and describes the formal evaluation of ProTEST by the London School of Hygiene & Tropical Medicine, including cost-effectiveness analyses and behaviour surveys.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "hiv interventions",
          "heading": true
        },
        {
          "term": "protest approach",
          "heading": false
        },
        {
          "term": "formal evaluation",
          "heading": false
        },
        {
          "term": "joint",
          "heading": true
        },
        {
          "term": "vct",
          "heading": false
        },
        {
          "term": "behaviour survey",
          "heading": false
        },
        {
          "term": "project sites",
          "heading": false
        },
        {
          "term": "progress",
          "heading": true
        }
      ],
      "extract": "PROGRESS WITH JOINT TB/HIV INTERVENTIONS Progress with joint TB/HIV interventions 3 3.1 3.1.1 with programmes supported by other agencies such as GFATM, CDC and USAID; the holding of implementation workshops; capacity development; the standardisation of indicators; improved monitoring and evaluation; and the provision of technical assistance to countries implementing joint TB and HIV/AIDS programme activities.",
      "extractCut": true
    },
    {
      "id": "sec-010-32-country-experiences",
      "number": "3.2",
      "title": "Country experiences",
      "level": 2,
      "pageStart": 23,
      "pageEnd": 32,
      "labelStart": "22",
      "labelEnd": "31",
      "words": 2738,
      "summary": {
        "text": "Reports country experiences of joint TB/HIV activities in Ethiopia, Kenya, South Africa and other countries, with data on TB incidence, HIV prevalence, treatment success and programme challenges. It describes efforts to decentralise DOTS, expand testing and preventive therapy, and coordinate with partners. The section ends with break-out group conclusions that scaling up requires better staffing, adherence to prophylaxis and community involvement.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vct centres",
          "heading": false
        },
        {
          "term": "vct clients",
          "heading": false
        },
        {
          "term": "offered vct",
          "heading": false
        },
        {
          "term": "vct services",
          "heading": false
        },
        {
          "term": "vct promotion",
          "heading": false
        },
        {
          "term": "hbc volunteer",
          "heading": false
        },
        {
          "term": "hbc coordinator",
          "heading": false
        },
        {
          "term": "joint activities",
          "heading": false
        }
      ],
      "extract": "Ethiopia Dr Berhane Kidane-Mariam (TB and Leprosy Programme Manager, Ethiopia) spoke on TB/HIV collaborative efforts in Ethiopia, where only 52% of the 65 million population are covered by health services. The estimated incidence of TB SECOND MEETING OF THE GLOBAL WORKING GROUP ON TB/HIV 22 3.1.2 3.2 3.2.1 is 260/100,000 (all forms) and 109/100,000 (smear-positive). HIV prevalence stands at around 7%. There have",
      "extractCut": true
    },
    {
      "id": "sec-011-41-presentation-of-the-guidelines",
      "number": "4.1",
      "title": "Presentation of the guidelines",
      "level": 2,
      "pageStart": 32,
      "pageEnd": 32,
      "labelStart": "31",
      "labelEnd": "31",
      "words": 114,
      "summary": {
        "text": "Recalls the philosophy of the global TB/HIV framework, a shift from separate programmes to a unified strategy combining DOTS with TB prevention, HIV prevention and care for co-infected people.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "preventive treatment",
          "heading": false
        },
        {
          "term": "hiv aids",
          "heading": false
        },
        {
          "term": "decrease",
          "heading": false
        },
        {
          "term": "arts",
          "heading": false
        }
      ],
      "extract": "Dr Fabio Scano (Stop TB Department, WHO) reminded participants of the philosophy of the global strategic framework to decrease the burden of TB/HIV: TB and HIV/AIDS programmes had largely pursued separate courses, despite overlapping TB/HIV epidemiology, but now there was a shift to a strengthened unified health sector strategy to control TB/HIV as an integral part of the response to HIV/AIDS. This new approach",
      "extractCut": true
    },
    {
      "id": "sec-012-activities",
      "number": null,
      "title": "activities",
      "level": 1,
      "pageStart": 32,
      "pageEnd": 33,
      "labelStart": "31",
      "labelEnd": "32",
      "words": 453,
      "summary": {
        "text": "Presents the draft guidelines for collaborative TB/HIV activities, their target audiences of district and national decision-makers, the steps they recommend starting with a situation analysis, and the timetable for finalising them and developing training tools.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vct centres",
          "heading": false
        },
        {
          "term": "stand-alone vct",
          "heading": false
        },
        {
          "term": "activities",
          "heading": true
        },
        {
          "term": "prioritised activity",
          "heading": false
        },
        {
          "term": "sti treatment",
          "heading": false
        },
        {
          "term": "programme activities",
          "heading": false
        },
        {
          "term": "activity charts",
          "heading": false
        },
        {
          "term": "quarter",
          "heading": false
        }
      ],
      "extract": "health districts, whilst recognising the need for reducing the burden of the two overlapping epidemics, may not be aware of potential collaborative activities and their benefits. The guidelines are intended for district policy-makers and health providers (for whom they need to be simple, practical, evidenced-based and adaptable, to enable rational planning and priority setting) and national policy makers and",
      "extractCut": true
    },
    {
      "id": "sec-013-42-discussion",
      "number": "4.2",
      "title": "Discussion",
      "level": 2,
      "pageStart": 33,
      "pageEnd": 34,
      "labelStart": "32",
      "labelEnd": "33",
      "words": 207,
      "summary": {
        "text": "Reports discussion of the guidelines, in which participants valued the first volume but disagreed on whether the second, evidence-based volume should be an annex or separate document. It was agreed to finish the guidelines within three months and make them simpler.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "volume",
          "heading": false
        },
        {
          "term": "discussion",
          "heading": true
        },
        {
          "term": "guidelines",
          "heading": false
        },
        {
          "term": "view",
          "heading": false
        },
        {
          "term": "agreed",
          "heading": false
        },
        {
          "term": "joint",
          "heading": false
        }
      ],
      "extract": "Participants were agreed that the first volume of the guidelines would make a valuable contribution to joint TB/HIV activities. (This volume provides background information and deals with the planning and implementation of joint programmes.) Discussion largely focused on the usefulness of the second volume, which dealt with the evidence and experience base (from ProTEST and other sources) that was used to compile",
      "extractCut": true
    },
    {
      "id": "sec-014-51-experience-in-brazil",
      "number": "5.1",
      "title": "Experience in Brazil",
      "level": 2,
      "pageStart": 34,
      "pageEnd": 34,
      "labelStart": "33",
      "labelEnd": "33",
      "words": 443,
      "summary": {
        "text": "Describes Brazil's provision of free universal antiretroviral therapy since 1996, with about 113 000 people treated by 2001, low primary drug resistance and estimated savings of US$1.8 billion on hospital and outpatient care.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "brazil",
          "heading": true
        },
        {
          "term": "hiv-related opportunistic",
          "heading": false
        },
        {
          "term": "haart",
          "heading": false
        },
        {
          "term": "hiv-infected individuals",
          "heading": false
        },
        {
          "term": "brazilian",
          "heading": false
        },
        {
          "term": "anti-retroviral",
          "heading": false
        },
        {
          "term": "five years",
          "heading": false
        },
        {
          "term": "moh",
          "heading": false
        }
      ],
      "extract": "Dr Marco Vitória of the Brazilian STD/AIDS Programme described Brazil’s action against HIV/AIDS, focusing on strategies implemented to provide universal, free anti-retroviral therapy to people living with HIV. This initiative began in 1991, with limited distribution of ZDV capsules, and was extended in 1996, when a presidential decree guaranteed free access to essential medication to all HIV-infected individuals.",
      "extractCut": true
    },
    {
      "id": "sec-015-5-anti-retroviral-treatment-art",
      "number": "5",
      "title": "Anti-retroviral treatment (ART)",
      "level": 1,
      "pageStart": 34,
      "pageEnd": 35,
      "labelStart": "33",
      "labelEnd": "34",
      "words": 68,
      "summary": {
        "text": "Notes that Brazil's experience shows AIDS treatment can work in a middle-income country, but questions whether this can be repeated in poorer countries with higher HIV prevalence.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "anti-retroviral treatment",
          "heading": true
        },
        {
          "term": "art",
          "heading": true
        },
        {
          "term": "incomes",
          "heading": false
        }
      ],
      "extract": "ANTI-RETROVIRAL TREATMENT (ART) Anti-retroviral treatment (ART) 5 5.1 The Brazilian experience demonstrates that effective AIDS treatment is feasible in a middle-income country - Brazil’s GNP per capita for 1999 was $4790. It has been shown that it can alter the natural history of coinfections, including TB. Whether the same results can be repeated in countries with significantly higher HIV prevalence rates, and",
      "extractCut": true
    },
    {
      "id": "sec-016-52-experience-in-malawi",
      "number": "5.2",
      "title": "Experience in Malawi",
      "level": 2,
      "pageStart": 35,
      "pageEnd": 35,
      "labelStart": "34",
      "labelEnd": "34",
      "words": 104,
      "summary": {
        "text": "Summarises Malawi's experience with antiretroviral therapy, highlighting drug supply, laboratory monitoring and the timing of treatment relative to TB therapy, and calls for demonstration projects and operational research.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "malawi",
          "heading": true
        },
        {
          "term": "art",
          "heading": false
        },
        {
          "term": "harries",
          "heading": false
        }
      ],
      "extract": "The presentation of Dr A Harries (see 3.2.4) included an account of Malawi’s experience with the use of ART. Challenges include safeguarding the drug supply and ensuring routine laboratory monitoring. The criteria for starting ART are crucial: too late in the decline of immune function and it will prevent little TB. If ART starts two months after TB treatment, it will not address the high percentage of TB deaths",
      "extractCut": true
    },
    {
      "id": "sec-017-53-who-guidelines",
      "number": "5.3",
      "title": "WHO guidelines",
      "level": 2,
      "pageStart": 35,
      "pageEnd": 36,
      "labelStart": "34",
      "labelEnd": "35",
      "words": 377,
      "summary": {
        "text": "Outlines WHO's new guidelines for antiretroviral therapy in resource-limited settings, aimed at policymakers, stressing potent three-drug regimens, standardisation, evidence-based recommendations and flexibility.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "reverse transcriptase",
          "heading": false
        },
        {
          "term": "hiv aids",
          "heading": false
        },
        {
          "term": "guidelines",
          "heading": true
        },
        {
          "term": "tlc",
          "heading": false
        },
        {
          "term": "hiv-infected individuals",
          "heading": false
        },
        {
          "term": "start",
          "heading": false
        },
        {
          "term": "regimens",
          "heading": false
        },
        {
          "term": "treatment",
          "heading": false
        }
      ],
      "extract": "Dr Charles Gilks (Department of HIV/AIDS/STIs, WHO) gave an overview of WHO’s recently published guidelines on the use of ART in resource-constrained countries.1 Primary audiences for the guidelines are national treatment advisory boards, AIDS programme managers, and other senior policymakers. They are not intended to be a clinical manual for patient management. Key considerations in the development of the",
      "extractCut": true
    },
    {
      "id": "sec-018-54-discussion",
      "number": "5.4",
      "title": "Discussion",
      "level": 2,
      "pageStart": 36,
      "pageEnd": 38,
      "labelStart": "35",
      "labelEnd": "37",
      "words": 147,
      "summary": {
        "text": "Reports discussion of the WHO antiretroviral guidelines, with calls for sharing adaptation experience and training health workers, and the conclusion that evidence from Brazil and South Africa justifies including HAART in joint TB/HIV activities.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "haart",
          "heading": false
        },
        {
          "term": "art",
          "heading": false
        },
        {
          "term": "concluded",
          "heading": false
        },
        {
          "term": "discussion",
          "heading": true
        }
      ],
      "extract": "The discussion that concluded this session centred on the WHO guidelines for ART. Participants expressed the need for a sharing of national and regional experience in adapting the guidelines to local situations. The need for training health workers in the use of ART was also stressed; WHO is already engaged in the development of guidelines. Participants concluded that the data from Brazil (especially when combined",
      "extractCut": true
    },
    {
      "id": "sec-019-61-the-impact-of-available-interventions",
      "number": "6.1",
      "title": "The impact of available interventions",
      "level": 2,
      "pageStart": 38,
      "pageEnd": 38,
      "labelStart": "37",
      "labelEnd": "37",
      "words": 393,
      "summary": {
        "text": "Describes a mathematical model of TB and HIV, illustrated with data from Kenya, used to explore the impact of interventions such as better TB cure and detection, latent TB treatment and antiretroviral therapy on TB incidence.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "reducing hiv",
          "heading": false
        },
        {
          "term": "hiv incidence",
          "heading": false
        },
        {
          "term": "interventions",
          "heading": true
        },
        {
          "term": "short run",
          "heading": false
        },
        {
          "term": "interventions target",
          "heading": false
        },
        {
          "term": "different interventions",
          "heading": false
        },
        {
          "term": "case detection",
          "heading": false
        },
        {
          "term": "dropout",
          "heading": false
        }
      ],
      "extract": "Christine Currie (Faculty of Mathematics, University of Southampton, UK) presented an epidemiological model of TB and HIV, and discussed its possible application. There are two sub-models: one for people who are HIV negative or at an early stage of the HIV disease, and one for people who are HIV-positive or are at a later stage of the disease. The model can be used to explore the impact of a range of different",
      "extractCut": true
    },
    {
      "id": "sec-020-6-directions-suggested-by-epidemiological-modell",
      "number": "6",
      "title": "Directions suggested by epidemiological modelling",
      "level": 1,
      "pageStart": 38,
      "pageEnd": 39,
      "labelStart": "37",
      "labelEnd": "38",
      "words": 12,
      "summary": {
        "text": "A section heading on directions suggested by epidemiological modelling.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "DIRECTIONS SUGGESTED BY EPIDEMIOLOGICAL MODELLING Directions suggested by epidemiological modelling 6 6.1",
      "extractCut": false
    },
    {
      "id": "sec-021-62-implications-of-an-analysis-of-the-tb-and-hiv",
      "number": "6.2",
      "title": "Implications of an analysis of the TB and HIV epidemics",
      "level": 2,
      "pageStart": 39,
      "pageEnd": 41,
      "labelStart": "38",
      "labelEnd": "40",
      "words": 1057,
      "summary": {
        "text": "Summarises an analysis of TB and HIV epidemic dynamics arguing that DOTS alone cannot control rising TB in East and southern Africa. It discusses added interventions such as preventive therapy, mass treatment and wide ART provision. Country projections suggest that only rapid DOTS expansion reduces TB, though the forecasts are uncertain.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "dots expansion",
          "heading": false
        },
        {
          "term": "cases attributable",
          "heading": false
        },
        {
          "term": "hiv",
          "heading": true
        },
        {
          "term": "highest number",
          "heading": false
        },
        {
          "term": "ranking countries",
          "heading": false
        },
        {
          "term": "hiv incidence",
          "heading": false
        },
        {
          "term": "epidemics",
          "heading": true
        },
        {
          "term": "hiv prevalence",
          "heading": false
        }
      ],
      "extract": "epidemics Dr Brian Williams (Stop TB, WHO) stressed the importance of taking a dynamic view of epidemics and for a broader perspective on the nature of TB/HIV interactions. In many East and southern African countries it seems clear that even reasonably good DOTS programmes are in themselves not sufficient to bring the rising epidemic of TB under control. Various other interventions which, if combined with DOTS, may",
      "extractCut": true
    },
    {
      "id": "sec-022-63-discussion",
      "number": "6.3",
      "title": "Discussion",
      "level": 2,
      "pageStart": 41,
      "pageEnd": 42,
      "labelStart": "40",
      "labelEnd": "41",
      "words": 616,
      "summary": {
        "text": "Reports discussion of the modelling, stressing regular monitoring of both epidemics at finer geographical scales and the importance of when ART is started. It lists conclusions, including a step-wise approach to scaling up and attention to human resources and management.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "count falls",
          "heading": false
        },
        {
          "term": "hiv activities",
          "heading": false
        },
        {
          "term": "falls below",
          "heading": false
        },
        {
          "term": "cell count",
          "heading": false
        },
        {
          "term": "misleading",
          "heading": false
        },
        {
          "term": "joint",
          "heading": false
        },
        {
          "term": "art",
          "heading": false
        },
        {
          "term": "opportunistic",
          "heading": false
        }
      ],
      "extract": "It was agreed that the presentations demonstrated the need for global and strategic thinking and for regular monitoring of both the TB and the HIV epidemics. National rates may be misleading given that there are very substantial intra-country variations in both TB and HIV, and ranking countries simply according to their national figures could in some cases be misleading. Given the size of some of the states in",
      "extractCut": true
    },
    {
      "id": "sec-023-7-constraints-and-recommendations-to-overcome-th",
      "number": "7",
      "title": "Constraints and recommendations to overcome them",
      "level": 1,
      "pageStart": 42,
      "pageEnd": 43,
      "labelStart": "41",
      "labelEnd": "42",
      "words": 14,
      "summary": {
        "text": "A section heading on constraints and recommendations to overcome them.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "CONSTRAINTS AND RECOMMENDATIONS TO OVERCOME THEM Constraints and recommendations to overcome them 7 7.1",
      "extractCut": false
    },
    {
      "id": "sec-024-72-advocacy-and-information-education-communicat",
      "number": "7.2",
      "title": "Advocacy and Information, Education & Communication",
      "level": 2,
      "pageStart": 43,
      "pageEnd": 43,
      "labelStart": "42",
      "labelEnd": "42",
      "words": 194,
      "summary": {
        "text": "Gives the advocacy and communication group's recommendations, such as simple messages, promoting TB treatment as a cost-effective way to cut AIDS deaths, and targeting audiences from UN theme groups and the Global Fund to health workers and communities.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "advocacy",
          "heading": true
        },
        {
          "term": "iec",
          "heading": false
        },
        {
          "term": "promoted",
          "heading": false
        },
        {
          "term": "message",
          "heading": false
        },
        {
          "term": "communication",
          "heading": true
        },
        {
          "term": "hiv",
          "heading": false
        }
      ],
      "extract": "Communication (Group 3) Advocacy and IEC both have a vital part to play in addressing TB/HIV. However, relatively few activities have yet been conducted and it is hard at this stage to make concrete recommendations. More needs to be done to establish what actually works. Advocacy and IEC activities must articulate the problems and specify the targets in a simple manner. Memorable slogans must be found! Advocacy is",
      "extractCut": true
    },
    {
      "id": "sec-025-73-surveillance-monitoring-and-evaluation",
      "number": "7.3",
      "title": "Surveillance, monitoring and evaluation",
      "level": 2,
      "pageStart": 43,
      "pageEnd": 44,
      "labelStart": "42",
      "labelEnd": "43",
      "words": 238,
      "summary": {
        "text": "Gives recommendations on surveillance, monitoring and evaluation, including agreed indicators, regular surveillance with feedback, measuring HIV prevalence among all TB patients and setting level-specific targets.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "surveillance",
          "heading": true
        },
        {
          "term": "targets",
          "heading": false
        },
        {
          "term": "hiv",
          "heading": false
        },
        {
          "term": "collaborative",
          "heading": false
        },
        {
          "term": "indicators",
          "heading": false
        },
        {
          "term": "agreed",
          "heading": false
        },
        {
          "term": "evaluation",
          "heading": true
        }
      ],
      "extract": "It was noted that collection of data had been stressed throughout the draft guidelines for collaborative TB/HIV activities. Data are required for effective programmes, and quality information can help win political commitment. The WG made the following recommendations. • Indicators must be agreed to help set objectives and goals. WHO’s work to identify suitable indicators must be completed as soon as possible and",
      "extractCut": true
    },
    {
      "id": "sec-026-74-provision-and-improvement-of-clinical-care",
      "number": "7.4",
      "title": "Provision and improvement of clinical care",
      "level": 2,
      "pageStart": 44,
      "pageEnd": 45,
      "labelStart": "43",
      "labelEnd": "44",
      "words": 438,
      "summary": {
        "text": "Recommends strengthening TB and HIV diagnosis and clinical care through district health systems, community action against stigma, removing access barriers, better staffing and linking antiretroviral programmes with TB programmes.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "arv programmes",
          "heading": false
        },
        {
          "term": "health system",
          "heading": false
        },
        {
          "term": "referral",
          "heading": false
        },
        {
          "term": "clarify",
          "heading": false
        },
        {
          "term": "district",
          "heading": false
        },
        {
          "term": "staff",
          "heading": false
        },
        {
          "term": "laboratories",
          "heading": false
        },
        {
          "term": "strengthened",
          "heading": false
        }
      ],
      "extract": "Diagnosis (both of TB and of HIV) must be strengthened in general health services, and at TB, HIV and VCT treatment sites. This will require the following. • Strengthening the health system, particularly at district level. District health management should play a more central role. Collaboration between medical and other sectors should be improved. • Acting in the community to increase awareness of signs/symptoms",
      "extractCut": true
    },
    {
      "id": "sec-027-75-scaling-up-joint-activities",
      "number": "7.5",
      "title": "Scaling up joint activities",
      "level": 2,
      "pageStart": 45,
      "pageEnd": 46,
      "labelStart": "44",
      "labelEnd": "45",
      "words": 303,
      "summary": {
        "text": "Recommends expanding the evidence base through phased implementation and lists core joint activities to consider, such as counselling and testing, preventive therapies and antiretroviral treatment. It stresses starting with a national situation analysis and protecting core DOTS programmes during scale-up.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "activities",
          "heading": true
        },
        {
          "term": "preventive treatment",
          "heading": false
        },
        {
          "term": "human resources",
          "heading": false
        },
        {
          "term": "scaling",
          "heading": true
        },
        {
          "term": "attrition",
          "heading": false
        },
        {
          "term": "dots",
          "heading": false
        },
        {
          "term": "joint",
          "heading": true
        },
        {
          "term": "sought",
          "heading": false
        }
      ],
      "extract": "(Group 6) • The WG urged WHO and partners to continue and expand their work to establish the evidence base for TB/HIV interventions through phased implementation of nationally defined core activities. • Joint activities will vary but the following must always be considered for inclusion: syndromic management of sexually transmitted infections, voluntary counselling and testing for HIV, active case finding, isoniazid",
      "extractCut": true
    },
    {
      "id": "sec-028-76-summary-of-key-recommendations",
      "number": "7.6",
      "title": "Summary of key recommendations",
      "level": 2,
      "pageStart": 46,
      "pageEnd": 55,
      "labelStart": "45",
      "labelEnd": null,
      "words": 1520,
      "summary": {
        "text": "Summarises the working group's key recommendations, including a proposed 2003 World Health Assembly resolution on joint TB/HIV activities, finalising the guidelines and an AIDS care strategy, and actions on funding, research and capacity. It ends with the meeting agenda (Annex 1) and the heading of the participant list (Annex 2).",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "urges governments",
          "heading": false
        },
        {
          "term": "hiv activities",
          "heading": false
        },
        {
          "term": "hiv working",
          "heading": false
        },
        {
          "term": "hiv aids",
          "heading": false
        },
        {
          "term": "working group",
          "heading": false
        },
        {
          "term": "anti-retroviral drugs",
          "heading": false
        },
        {
          "term": "global working",
          "heading": false
        },
        {
          "term": "phased implementation",
          "heading": false
        }
      ],
      "extract": "1. In recognition that control of TB in high HIV prevalence settings requires full implementation of the DOTS strategy and incorporation of additional joint TB/HIV activities, the WG urges WHO: • to submit a resolution to the WHA in 2003 that urges governments to implement an HIV/AIDS care strategy and country-level implementation of joint TB/HIV activities, as set out in the Global TB /HIV Strategic Framework •",
      "extractCut": true
    },
    {
      "id": "sec-029-annex-2-list-of-participants",
      "number": "Annex 2",
      "title": "List of participants",
      "level": 1,
      "pageStart": 55,
      "pageEnd": 66,
      "labelStart": null,
      "labelEnd": null,
      "words": 3307,
      "summary": {
        "text": "The list of meeting participants, giving names, titles, organisations and contact details for people from national AIDS and tuberculosis programmes, research projects, donors and WHO, ending with WHO tuberculosis programme contact details printed with spaced-out letters.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "tel fax",
          "heading": false
        },
        {
          "term": "tbs stb",
          "heading": false
        },
        {
          "term": "tbp stb",
          "heading": false
        },
        {
          "term": "e-mail",
          "heading": false
        },
        {
          "term": "avenue appia",
          "heading": false
        },
        {
          "term": "keppel street",
          "heading": false
        },
        {
          "term": "private bag",
          "heading": false
        },
        {
          "term": "deputy director",
          "heading": false
        }
      ],
      "extract": "54 Dr P.I. Alade National Action Committee on AIDS, (NACA), Special Assistant to Chairman, The Presidency Block 3A Room 1,44 - 1.48 (1st Floor) Federal Secretariat Complex, Abuja Nigeria Tel/Fax:+234-9-523-4253 E-mail: nacaabj@yahoo.com or nacaabj@email.com Dr Helen Ayles Project Coordinator ZAMBART Project c/o Department of Medicine UTH, P.O. Box 50110 Lusaka, Zambia Tel: +260-1-254-710 Fax: +260-1-254-710 E-mail:",
      "extractCut": true
    }
  ],
  "checks": {
    "tocAlignment": {
      "listed_not_found": {
        "count": 2,
        "items": [
          "Report",
          "Meeting agenda"
        ]
      },
      "found_not_listed": {
        "count": 0,
        "items": []
      },
      "page_mismatch": {
        "count": 1,
        "items": [
          "activities: listed p32, found p49"
        ]
      }
    },
    "figureSequenceGaps": [],
    "pageLabelConflicts": {
      "count": 0,
      "items": []
    }
  },
  "withheld": false,
  "keywords": [
    {
      "term": "hiv aids",
      "heading": false
    },
    {
      "term": "hiv activities",
      "heading": false
    },
    {
      "term": "hiv working",
      "heading": false
    },
    {
      "term": "national hiv",
      "heading": false
    },
    {
      "term": "hiv guidelines",
      "heading": false
    },
    {
      "term": "control hiv",
      "heading": false
    },
    {
      "term": "hiv programmes",
      "heading": false
    },
    {
      "term": "hiv interventions",
      "heading": true
    },
    {
      "term": "hiv prevalence",
      "heading": false
    },
    {
      "term": "hiv patients",
      "heading": false
    },
    {
      "term": "hiv collaboration",
      "heading": false
    },
    {
      "term": "joint activities",
      "heading": true
    }
  ],
  "pageLabels": [
    {
      "physical": 1,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 2,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 3,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 4,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 5,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 6,
      "label": "5",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 7,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 8,
      "label": "7",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 9,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 10,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 11,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 12,
      "label": "11",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 13,
      "label": "12",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 14,
      "label": "13",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 15,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 16,
      "label": "15",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 17,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 18,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 19,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 20,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 21,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 22,
      "label": "21",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 23,
      "label": "22",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 24,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 25,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 26,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 27,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 28,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 29,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 30,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 31,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 32,
      "label": "31",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 33,
      "label": "32",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 34,
      "label": "33",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 35,
      "label": "34",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 36,
      "label": "35",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 37,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 38,
      "label": "37",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 39,
      "label": "38",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 40,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 41,
      "label": "40",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 42,
      "label": "41",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 43,
      "label": "42",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 44,
      "label": "43",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 45,
      "label": "44",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 46,
      "label": "45",
      "source": "contents",
      "confidence": 0.6
    },
    {
      "physical": 47,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 48,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 49,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 50,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 51,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 52,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 53,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 54,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 55,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 56,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 57,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 58,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 59,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 60,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 61,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 62,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 63,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 64,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 65,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 66,
      "label": null,
      "source": null,
      "confidence": 0
    }
  ],
  "figures": [],
  "coverage": [
    {
      "kind": "contents",
      "state": "found",
      "count": 31,
      "note": "inferred"
    },
    {
      "kind": "sections",
      "state": "found",
      "count": 31,
      "note": "2 levels"
    },
    {
      "kind": "figures",
      "state": "none"
    },
    {
      "kind": "tables",
      "state": "not-extracted"
    },
    {
      "kind": "references",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "glossary",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "footnotes",
      "state": "not-extracted"
    },
    {
      "kind": "summaries",
      "state": "found",
      "count": 31,
      "note": "31 of 31 sections"
    }
  ],
  "links": {
    "repo": "litlfred/who-iris",
    "branch": "main",
    "dir": "library/10665-67839"
  }
}
